Spots Global Cancer Trial Database for selinexor 80 mg
Every month we try and update this database with for selinexor 80 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma | NCT04661137 | Multiple Myelom... | Selinexor 60 MG Selinexor 80 MG Selinexor 100 M... Carfilzomib Pomalidomide Daratumumab Dexamethasone | 18 Years - | Hackensack Meridian Health | |
Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment | NCT04256707 | Non-Small Cell ... Colorectal Canc... Other Solid Tum... | Selinexor 100 m... Docetaxel Pembrolizumab FOLFIRI Selinexor 40 mg Selinexor 80 mg Selinexor 60 mg | 18 Years - | Karyopharm Therapeutics Inc |